Preclinical investigation of tolerance and antitumour activity of new fluorodeoxyglucose-coupled chlorambucil alkylating agents.
about
Novel harmine derivatives for tumor targeted therapy.Designing polymers with sugar-based advantages for bioactive delivery applicationsGlucose conjugation for the specific targeting and treatment of cancer.Advances in the development of hybrid anticancer drugs.Small Molecules for Active Targeting in Cancer.Doxycycline and its quaternary ammonium derivative for adjuvant therapies of chondrosarcoma.
P2860
Preclinical investigation of tolerance and antitumour activity of new fluorodeoxyglucose-coupled chlorambucil alkylating agents.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Preclinical investigation of t ...... hlorambucil alkylating agents.
@ast
Preclinical investigation of t ...... hlorambucil alkylating agents.
@en
Preclinical investigation of t ...... hlorambucil alkylating agents.
@nl
type
label
Preclinical investigation of t ...... hlorambucil alkylating agents.
@ast
Preclinical investigation of t ...... hlorambucil alkylating agents.
@en
Preclinical investigation of t ...... hlorambucil alkylating agents.
@nl
prefLabel
Preclinical investigation of t ...... hlorambucil alkylating agents.
@ast
Preclinical investigation of t ...... hlorambucil alkylating agents.
@en
Preclinical investigation of t ...... hlorambucil alkylating agents.
@nl
P2093
P2860
P1476
Preclinical investigation of t ...... hlorambucil alkylating agents.
@en
P2093
Bastien Reux
Elisabeth Miot-Noirault
Eric Debiton
Jean-Claude Madelmont
Jean-Michel Chezal
Pascal Coudert
Valérie Weber
P2860
P2888
P304
P356
10.1007/S10637-009-9371-0
P577
2009-12-23T00:00:00Z
P6179
1023968272